Details for Patent: 10,945,988
✉ Email this page to a colleague
Which drugs does patent 10,945,988 protect, and when does it expire?
Patent 10,945,988 protects HETLIOZ and is included in one NDA.
This patent has one hundred and forty-seven patent family members in twenty-three countries.
Drugs Protected by US Patent 10,945,988
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vanda Pharms Inc | HETLIOZ | tasimelteon | CAPSULE;ORAL | 205677-001 | Jan 31, 2014 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | TREATMENT OF NON-24 HOUR SLEEP-WAKE DISORDER BY ADMINISTERING TASIMELTEON | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,945,988
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2013211878 | ⤷ Try a Trial | |||
Australia | 2013211880 | ⤷ Try a Trial | |||
Australia | 2013361459 | ⤷ Try a Trial | |||
Australia | 2015206797 | ⤷ Try a Trial | |||
Australia | 2016204178 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |